Hikma Strikes Deal For Celltrion’s Yuflyma

Firms Agree MENA Licensing Deal For High-Concentration Adalimumab Biosimilar

 
• By David Wallace
  
MENA Region Red Background Map
Hikma has once again expanded its MENA biosimilars portfolio • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products